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Summary Extracolonic Clostridium difficile infections have been infrequently reported.
Extracolonic manifestations of C. difficile include bacteremia, intra-abdominal abscess, osteo-
myelitis, visceral abscess, empyema, reactive arthritis, and small bowel disease with formation
of pseudomembranes on ileal mucosa. Most cases of extracolonic C. difficile have been preceded
by gastrointestinal disease, either C. difficile colitis or surgical and anatomical disruption of the
colon. Bacteremia due to C. difficile has previously been described in 14 patients with underlying
gastrointestinal processes. We report a unique case of monomicrobial C. difficile bacteremia in a
young woman with an underlying hematologic malignancy. The patient lacked gastrointestinal
symptoms or radiologic findings suggestive of colitis or ongoing gastrointestinal pathology.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Clostridium difficile is well recognized as an etiologic agent
of pseudomembranous colitis. Clinical disease with C. diffi-
cile toxin has historically been associated with prior anti-
biotic exposure and is the cause of 20—25% of all antibiotic-
associated diarrhea. C. difficile-related colitis is associated
with significant healthcare costs, prolonged hospitalizations,
and increased morbidity.1
C. difficile infection is characterized by diarrhea and a
variety of constitutional symptoms such as fever, abdominal
pain, cramping, malaise, nausea, and anorexia. Laboratory
findings include leukocytosis and fecal leukocytes. Stool tests
are frequently positive for C. difficile toxin by ELISA in the* Corresponding author. Tel.: +1 804 828 2121.
E-mail address: gbearman@vcu.edu (G. Bearman).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.01.014presence of C. difficile-associated diarrhea and colitis. The
infected colonic mucosa appears as a raised, studded white
and yellow plaque characteristic of pseudomembranous coli-
tis. Biopsy of plaques reveals inflamed mucosa with neutro-
philic predominance and mucin-distended glands.2
In contrast, extracolonic infections have been reported
rarely.3—16 Extracolonic manifestations of C. difficile include
bacteremia, osteomyelitis, visceral abscess, empyema, reac-
tive arthritis, and small bowel disease with the formation of
pseudomembranes on the ileal mucosa. Most cases of extra-
colonic C. difficile have been preceded by gastrointestinal
disease, either C. difficile colitis or surgical and anatomical
disruption of the colon.3
We summarize the literature on polymicrobial C. difficile
bacteremia and present a unique case of monomicrobial C.
difficile bacteremia in a patient without evidence of con-
comitant gastrointestinal disease.Published by Elsevier Ltd. All rights reserved.
Table 1 Extracolonic manifestations of Clostridium diffi-
cile reported in the literature
Bacteremia
Peritonitis
Intra-abdominal abscess
Abdominal wound infection
Brain abscess
Pyelonephritis
Reactive arthritis
Cellulitis
Necrotizing fasciitis
Visceral abscesses
Empyema
Osteomyelitis
Prosthetic joint infections
Chronic osteomyelitis
Reactive arthritis
Appendicitis
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A 40-year-old African-American female with a past medical
history of dermatomyositis, treated with high dose predni-
sone, presented with several months of left upper quadrant
pain, increasing fatigue, andan18 kgweight loss. Therewasno
history of diarrhea, constipation, or changes in her bowel and
urinary habits. Her initial evaluation included a complete
blood count revealing a white blood cell count of 17.4  109
cells/l and hemoglobin of 8.6 g/dl. Ametabolic panel revealed
no abnormalities in renal function, electrolytes, or liver func-
tion. Computed tomography with both oral and intravenous
contrast of the abdomen and pelvis demonstrated mild sple-
nomegaly with several small splenic infarcts, a subcentimeter
liver mass, and peri-aortic lymphadenopathy. As an outpati-
ent, she was empirically treated with an unknown antibiotic
for a 7-day course. When seen in follow-up for a lymph node
biopsy, routine pre-operative labs showed a white blood cell
count of 45.64  109 cells/l and she was referred to the
tertiary care center for further evaluation.
On admission, her vital signs were stable and physical
exam findings significant only for left axillary adenopathy and
splenomegaly percussed to 8 cm below the costal border. A
peripheral blood smear showed leukoerythroblastic changes,
increased monocytes, left-shifted myeloid precursors, dys-
plastic cells, and large platelets suggestive of chronic mono-
cytic myelogenous leukemia versus myeloproliferative
disorder. Other significant findings included lactose dehydro-
genase of 1026 U/l and chest radiograph findings of mild
cardiomegaly and elevated left hemidiaphragm without air-
space disease. Hydroxyurea and allopurinol were initiated for
the prevention of tumor lysis syndrome.
On hospital day 3 she developed fever to 38.6 8C and
tachycardia. Her hemoglobin decreased to 7.7 g/dl and pla-
telet count decreased to 67  109 cells/l. Urine culture and
two sets of peripheral blood cultures were obtained. A bone
marrow biopsy was performed and the diagnosis of acute
myelogenous leukemia was confirmed. On hospital day 5,
empiric cefepime, metronidazole and intravenous vancomy-
cin were begun when the laboratory initially reported Gram-
positive rods in one anaerobic blood culture bottle. Within
24 hours, blood cultures in two anaerobic bottles were fina-
lized as C. difficile. Computed tomography of the abdomen
and pelvis was repeated and revealed marked hepatosple-
nomegaly with infarcts and lymphomatous infiltration,
extensive adenopathy, a small amount of non-specific fluid
around the gallbladder, and no evidence of abscess or bowel
wall thickening. No symptoms of abdominal distention, pain,
or diarrhea were reported, consequently, laboratory confir-
mation of C. difficile toxin in the stool was not requested by
the medical team. On hospital day 7 the patient became
febrile to 39.5 8C, hypotensive, and was intubated for
respiratory failure. Her white blood cell count increased to
248.4  109 cells/l with 12% blasts. Despite aggressive med-
ical therapy, the patient died within 12 hours after develop-
ing septic shock.
Discussion and literature review
Clostridium difficile is an anaerobic, Gram-positive, spore-
forming rod that asymptomatically colonizes the gastroin-
testinal tract in 2—3% of healthy adults and 40% ofneonates.17 C. difficile colitis continues to have increasing
clinical significance as a complication of antibiotic therapy.
The classic clinical presentation of C. difficile antibiotic-
associated diarrhea is fever, diarrhea, and leukocytosis
occurring several days to months after antibiotic exposure.2
Extracolonic C. difficile is rarely reported and has historically
been of questionable clinical significance. However, with an
increase in the incidence of colitis, there has been an asso-
ciated increase in cases of extracolonic C. difficile.5
Reported manifestations include small bowel disease, bac-
teremia, visceral abscess formation (splenic abscess, pan-
creatic abscess, empyema and pleural effusion), prosthetic
device infections, encephalopathy, reactive arthritis, osteo-
myelitis, and soft tissue infections.3,5—10,12 Almost all cases
of extracolonic C. difficile are related to colonic disease
(with or without perforation) and have low reported overall
morbidity and mortality.3,5—10
Chatila and Manthous11 described a ‘sepsis-syndrome’ in
1995 in four patients; three further cases were reported by
Lowenkron et al. in 1996.14 These cases describe severe
pseudomembranous colitis with resultant deterioration
requiring mechanical ventilation, broad-spectrum antibio-
tics, and presser support for hypotension. None of these
cases had positive blood cultures. Chatila and Manthous11
suggested that the sepsis syndrome associated with C. dif-
ficile is the result of a cellular inflammatory response to
either severe enterocolitis alone or to other factors such as
toxin A and B activation of a host monocyte and neutrophilic
chemoattractant response. In this model, the translocation
of endo- and exotoxins across the damaged gut mucosa
results in cytokine inactivation and a systemic inflammatory
reaction.
Extracolonic manifestations of C. difficile have been
reported3 (Table 1). Transient C. difficile bacteremia has
been implicated as a route of transmission of extracolonic
infections such as osteomyelitis, visceral abscess, and pros-
thetic joint infections. Positive blood cultures, however,
have rarely been reported.3 Garcia-Lechuz et al. reported
17 cases of extracolonic C. difficile from a single institution
over a 10-year period. Peritonitis, intra-abdominal abscess,
Table 4 Summary of all Clostridium difficile bacteremia
Ref. Age/sex Presenting signs Prior
antibiotic
exposure
Stool toxin Concomitant
blood-borne
pathogens
Treatment Outcome
16 65/M Axillo-femoral bypass,
diarrhea at 6 days,
bacteremia 10 days
Yes Unknown Bacteroides fragilis Cefuroxime,
metronidazole
Recovered
13 39/M Left mandible
radionecrosis,
hypotension, fevers
Not
reported
Unknown Escherichia coli,
enterococci, Bacteroides
vulgatus
Vancomycin,
metronidazole,
pefloxacin
Recovered
8 85/F Cerebral vascular
accident, recurrent
diarrhea
Yes Positive Enterococcus faecalis Vancomycin,
gentamycin
Recovered
5 17/M Ileus with partial small
bowel obstruction
Yes Not tested Candida parapsilosis Unknown Recovered
5 33/F Pelvic abscess and
recto-vaginal fistula
after radiotherapy
Yes Not tested Fusobacterium sp,
C. cadaverius, Bacteroides
melaninogenicus
Unknown Died
5 77/M Perforated sigmoid
diverticulum
Yes Not tested Eubacterium lentum Unknown Died
10 3/M Pericarditis, pericardial
effusion, diarrhea
Yes Not tested None Vancomycin Recovered
12 18/M Fever, chills, abdominal
pain, diarrhea
Yes Unknown None Vancomycin Unknown
12 78/M Trauma, febrile, diarrhea Yes Unknown None Vancomycin Died
15 5 mo Cough, coryza, diarrhea Yes Not tested Bacteroides fragilis Unknown Unknown
9 35/F Acute myeloid leukemia,
diarrhea, jaundice
Yes Positive Bacteroides sp,
group D streptococci
Vancomycin,
metronidazole
Died
9 69/F Acute lymphoblastic
leukemia, abdominal
distension and pain
Yes Not tested Bacteroides sp,
Escherichia coli
Metronidazole Relapsed
9 Recurrence–—sudden
abdominal distension,
toxic megacolon,
psoas abscess
Yes Positive Bacteroides sp,
Escherichia coli
Vancomycin 
metronidazole
Died
6 66/M Intestinal invasion
of bladder cancer,
pyelonephritis
Not reported Not tested Bacteroides fragilis,
vancomycin-resistant
enterococci
Imipenem Died
6 65/M Cardiac surgery,
ischemic colitis
Not reported Not tested Enterococcus faecium,
Bacteroides ovatus
Ceftriaxone,
ciprofloxacin
Died
Current
case
40/F Acute myeloid
leukemia, fatigue,
weight loss, no diarrhea
Yes Not tested None Vancomycin,
cefepime,
metronidazole
Died
Table 2 Co-pathogens reported in polymicrobial Clostri-
dium difficile bacteremia
Bacteroides fragilis
Escherichia coli
Enterococcus faecalis
Bacteroides vulgatus
Candida parapsilosis
Fusobacterium sp
C. cadaverius
Bacteroides melaninogenicus
Group D streptococci
Vancomycin-resistant enterococci
Table 3 Concomitant gastrointestinal pathology reported
in cases of Clostridium difficile bacteremia
Diarrhea
Small bowel obstruction
Pelvic abscess and rectovaginal fistula
Perforated sigmoid diverticulum
Jaundice
Ischemic colitis
Toxic megacolon
Psoas abscess
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cases. Additionally, brain abscess, chronic osteomyelitis, and
pyelonephritis were each reported.6 Jacobs et al. described
extracolonic C. difficile infections of the small bowel and
reactive arthritis.7 Cellulitis,15 necrotizing fasciitis,18 visc-
eral abscesses,19 empyema,18 osteomyelitis,19 prosthetic
joint infections,20 and appendicitis21 have also been reported
in the literature. Of these extracolonic infections, most were
polymicrobial and commonly involved the enteric
flora.3,15,17—21
There are 15 reported cases of C. difficile bacteremia in
the English literature. The first report was in 1962 in a 5-
month-old baby with cough, coryza, and anorexia.15 Twelve
of 15 cases had mixed Gram-negative and/or anaerobic
bacteremia, most typically gut flora (Table 2). All cases of
C. difficile bacteremia in adults had concomitant gastro-
intestinal pathology of varying severity (Table 3). Two
patients with polymicrobial C. difficile bacteremia had
underlying hematologic malignancies. One patient had
two separate episodes of C. difficile bacteremia with
interval worsening of gastrointestinal disease.9 Seven
patients (50%) died within 7 days, five patients were dis-
charged from the hospital, and two outcomes were not
reported. All but three patients had prior antibiotic expo-
sure. The results of a stool toxin assay were described in
only three cases. All but three of the 15 cases of C. difficile
bacteremia were polymicrobial. All cases of monomicrobial
C. difficile bacteremia were in adult patients with con-
comitant fever, abdominal pain, and diarrhea.6 In our case,
the patient had both an underlying hematologic malignancy
and monomicrobial bacteremia, yet exhibited neither
symptoms of gastrointestinal disease nor findings sugges-
tive of colitis or abscess on repeat abdominal imaging
(Table 4).
Treatment of bacteremia as well as other sites of extra-
colonic C. difficile infection has varied in the literature. As
most infections appear to be polymicrobial in nature, therapy
has been directed at all organisms.3,5—10,12,13 In addition to
antibiotics directed at other identified pathogens, intrave-
nous vancomycin or metronidazole was utilized in all but six
cases of bacteremia with reported treatment regimens.
Despite aggressive therapy, seven of 14 patients died. The
attributable mortality from extracolonic C. difficile is diffi-
cult to assess, as rigorously matched case—control studies do
not exist. Most patients with extracolonic C. difficile bacter-
emia had severe underlying disease that predisposed them to
a high crude mortality.3,6
Although the source of our patient’s C. difficile bacter-
emia remains undefined, the likelihood of having undiag-
nosed C. difficile colitis seems remote given the absence of
diarrhea and radiographic manifestations of colitis on com-
puted tomography. Rather, the patient may have been
colonized with C. difficile. Subsequently, the resultant
monomicrobial bacteremia was likely secondary to bacter-
ial translocation in the setting of immunologic deficiency
from an overwhelming, acutely progressing myelogenous
leukemia.
Conclusions
Extraintestinal C. difficile infection, including bacteremia,
has been reported infrequently. C. difficile bacteremia istypically associated with underlying gastrointestinal
pathology and frequently occurs as a mixed infection with
other gut flora. We have reported a unique case of mono-
microbial C. difficile bacteremia in a young woman with an
underlying hematologic malignancy. The patient lacked
gastrointestinal findings suggestive of colitis or other
ongoing gastrointestinal pathology. C. difficile bacteremia
appears to have a crude mortality rate reaching approxi-
mately 50%. This review and case report adds to the body
of literature on the extraintestinal manifestations of
C. difficile disease.
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